MRI Study of Eating Behavior for Bulimia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how individuals with bulimia nervosa (BN) make decisions about eating and control, particularly when hungry or full. Researchers use MRI (Magnetic Resonance Imaging) scans to observe brain activity in both states, aiming to better understand these decision-making processes. The trial is open to right-handed women who speak English, have a BMI between 18.5 and 30, and meet the DSM-5 criteria for bulimia nervosa. Participants contribute to research that may reveal whether changing eating patterns can enhance BN treatment. As an unphased trial, this study allows participants to contribute to foundational research that could lead to improved treatments for bulimia nervosa.
Do I need to stop taking my current medications to join the trial?
The trial excludes participants with ongoing medical treatment that may interfere with the study, so you might need to stop certain medications. It's best to discuss your specific medications with the trial team.
What prior data suggests that Magnetic Resonance Imaging is safe for studying eating behavior in individuals with bulimia nervosa?
Research has shown that Magnetic Resonance Imaging (MRI) is safe for studying brain activity. Many studies have used this technology with individuals who have bulimia nervosa and other eating disorders. Reports indicate that MRI is generally comfortable, with participants usually not experiencing problems or discomfort during the procedure. The studies mentioned have not reported any serious negative effects. As a common and trusted tool in medical research, MRI is unlikely to cause harm or side effects for participants.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different states of eating—fasting versus fed—affect brain activity in individuals with and without bulimia, using MRI technology. Unlike current bulimia treatments that focus on behavior therapy and medication, this approach aims to uncover the neurological patterns linked to eating behaviors. By understanding these brain patterns, scientists hope to develop more targeted and effective interventions for bulimia nervosa in the future.
What evidence suggests that this trial's treatments could be effective for bulimia?
This trial will use MRI to study eating behavior in participants with and without bulimia nervosa. Research has shown that brain scans, like MRI, can reveal how bulimia affects the brain. MRI studies have found changes in brain areas that control decision-making in people with bulimia. These changes might make it harder for them to stop binge eating and purging. For example, some brain parts may not function as well, making it difficult to resist these behaviors. Understanding these brain differences can lead to better treatments for managing eating habits. MRI allows researchers to see these differences clearly, providing important insights into bulimia.36789
Who Is on the Research Team?
Laura A Berner, Ph.D.
Principal Investigator
Mount Sinai Icahn School of Medicine
Are You a Good Fit for This Trial?
This trial is for right-handed, English-speaking females aged 18-45 with a BMI between 18.5 and under 30 who meet the criteria for bulimia nervosa. It's not suitable for those medically unstable, on ongoing treatment, doing shift work, pregnant or lactating, allergic to meal ingredients used in the study, or unable to undergo an fMRI.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo fMRI scans after fasting and after a standardized meal to assess neural activation related to cognitive control in bulimia nervosa
Follow-up
Participants are monitored for changes in binge-eating, dietary restriction, and compensatory behaviors
What Are the Treatments Tested in This Trial?
Interventions
- Fasting state
- Fed state
- Magnetic Resonance Imaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator